Author Archives: rtushnet

compounding pharmacy must face drugmaker’s Lanham Act claims based on false 503B compliance statements

Posted on August 17, 2026 by rtushnet

Pacira BioSciences, Inc. v. Nephron Sterile Compounding Center, LLC, No. 3:23-cv-05552-CMC, 2026 WL 2267750 (D.S.C. Aug. 6, 2026) Pacira sells an FDA-approved pain management drug called EXPAREL. Nephron allegedly made various false and misleading statements about two of Nephron’s competing … Continue reading →

Posted in Uncategorized | Tagged , , , | Leave a comment

anti-Chinese memory chips blog & report weren’t commercial speech despite alleged competitor funding

Posted on August 17, 2026 by rtushnet

Yangtze Memory Technologies, Inc. v. Micron Technology, Inc., 2026 WL 2350276, No. 1:25-cv-01795 (CJN) (D.D.C. Aug. 13, 2026) On the one hand, there’s a risk of suppressing valuable noncommercial speech if we apply the Lanham Act too broadly; on the … Continue reading →

Posted in Uncategorized | Tagged , | Leave a comment

heavy weather for heavy metals in infant food

Posted on August 17, 2026 by rtushnet

Choudhry v. Mead Johnson & Co., 2026 WL 2349932, No. 25-cv-09480 (ER) (S.D.N.Y. Aug. 13, 2026) Plaintiffs alleged that various Enfamil infant formulas contained arsenic, cadmium, and lead, heavy metals that present significant health risks, particularly to young children, and … Continue reading →

Posted in Uncategorized | Tagged , | Leave a comment

a lot of balls: golf ball manufacturer states claim for allegedly false UV light comparison

Posted on August 14, 2026 by rtushnet

TaylorMade Golf Co. v. TopGolf Callaway Brands Corp., 2026 WL 2244259, No. 3:26-cv-250-GPC-BJW (S.D. Cal. Aug. 4, 2026) TaylorMade sued Callaway, a competitor in the golf ball market, for federal and state false advertising/unfair competition. TaylorMade alleged substantial investment in … Continue reading →

Posted in Uncategorized | Tagged | Leave a comment

“battery tender” isn’t generic for guess what, but keyword advertising is fine

Posted on August 14, 2026 by rtushnet

Deltona Transformer Corporation v. NOCO Company, — F.4th —-, 2026 WL 2236806, No. 24-13590 (11th Cir. Aug. 4, 2026) Competitors aren’t generally allowed the same freedom as consumers to “genericize” a term. Here, the 11th Circuit finds no error in … Continue reading →

Posted in Uncategorized | Tagged , | Leave a comment

is an avocado a vegetable or a fruit? Court says it’s ambiguous

Posted on August 14, 2026 by rtushnet

Parashos v. Once Upon A Farm, No. 26-cv-00314-EMC,  2026 WL 2283647 (N.D. Cal. Aug. 7, 2026) Once Upon A Farm allegedly violated California consumer protection laws by misleadingly labeling its baby product as the “Wild Rumpus Avocado ‘Fruit & Veggie … Continue reading →

Posted in Uncategorized | Leave a comment

trademark claim proceeds with essentially no detail, despite trade dress failure

Posted on August 13, 2026 by rtushnet

Honest Company, Inc., v. Butterblu, LLC, 2026 WL 2211834, No. 2:26-cv-00019-WLH-MBK (C.D. Cal. Jul. 28, 2026) Honest sued former partner Butterblu for trademark infringement and related claims. Honest sells products in the diaper and wipes, skin and personal care, and … Continue reading →

Posted in Uncategorized | Tagged , | Leave a comment

consumers face more skepticism than competitor in online gaming case

Posted on August 13, 2026 by rtushnet

Mitchell v. Skillz Platform Inc., 2026 WL 2212876, No. 26-cv-00674-AMO (N.D. Cal. Jul. 31, 2026) Although competitors can aggregate harm to sue under the Lanham Act, consumers—the direct victims of false advertising—tend to have more trouble. Skillz just lost a … Continue reading →

Posted in Uncategorized | Tagged , , | Leave a comment

Novo struggles once again to allege deception by sellers of compounded drugs

Posted on August 13, 2026 by rtushnet

Novo Nordisk v. Zealthy Inc., 2026 WL 2212889, No. 25-cv-06391 (ALC) (S.D.N.Y. Jul. 31, 2026) Novo Nordisk makes the FDA-approved Ozempic, Rybelsus, and Wegovy, while Zealthy markets and facilitates access to drug products, including compounded medications containing semaglutide. Novo alleged … Continue reading →

Posted in Uncategorized | Tagged , , | Leave a comment

not with a bang, but with a whimper of whipped dogs? VIP prevails in Ninth Circuit

Posted on August 13, 2026 by rtushnet

VIP Prods., LLC v. Jack Daniel’s Properties, Inc., No. 25-2027 (9th Cir. Aug. 4, 2026) VIP prevailed on remand on the confusion claim but lost on dilution by tarnishment. The court of appeals reversed, holding that JDI didn’t show that … Continue reading →

Posted in Uncategorized | Tagged , | Leave a comment